CHAPTER 1. Industry Overview of Coronary Stents Market
1.1. Definition and Scope
1.1.1. Definition of Coronary Stents
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Coronary Stents Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Coronary Stents Market By Type
1.2.3. Coronary Stents Market By Biomaterial
1.2.4. Coronary Stents Market By Mode of Delivery
1.2.5. Coronary Stents Market By End User
1.2.6. Coronary Stents Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Coronary Stents Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Coronary Stents Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. Coronary Stents Market By Type
5.1. Introduction
5.2. Coronary Stents Revenue By Type
5.2.1. Coronary Stents Revenue (USD Billion) and Forecast, By Type, 2020-2032
5.2.2. Bare Metal Stents
5.2.2.1. Bare Metal Stents Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. Drug Eluting Stent
5.2.3.1. Drug Eluting Stent Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3.2. Biodegradable
5.2.3.2.1. Biodegradable Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3.3. Non-Biodegradable
5.2.3.3.1. Non-Biodegradable Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.4. Bio-Absorbable Stent
5.2.4.1. Bio-Absorbable Stent Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. Coronary Stents Market By Biomaterial
6.1. Introduction
6.2. Coronary Stents Revenue By Biomaterial
6.2.1. Coronary Stents Revenue (USD Billion) and Forecast, By Biomaterial, 2020-2032
6.2.2. Metallic Biomaterials
6.2.2.1. Metallic Biomaterials Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3. Polymers Biomaterials
6.2.3.1. Polymers Biomaterials Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.4. Natural Biomaterials
6.2.4.1. Natural Biomaterials Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 7. Coronary Stents Market By Mode of Delivery
7.1. Introduction
7.2. Coronary Stents Revenue By Mode of Delivery
7.2.1. Coronary Stents Revenue (USD Billion) and Forecast, By Mode of Delivery, 2020-2032
7.2.2. Self Expandable Stent
7.2.2.1. Self Expandable Stent Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.3. Balloon Expandable Stent
7.2.3.1. Balloon Expandable Stent Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 8. Coronary Stents Market By End User
8.1. Introduction
8.2. Coronary Stents Revenue By End User
8.2.1. Coronary Stents Revenue (USD Billion) and Forecast, By End User, 2020-2032
8.2.2. Hospitals
8.2.2.1. Hospitals Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.3. Ambulatory Surgical Centers
8.2.3.1. Ambulatory Surgical Centers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.4. Other
8.2.4.1. Other Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 9. North America Coronary Stents Market By Country
9.1. North America Coronary Stents Market Overview
9.2. U.S.
9.2.1. U.S. Coronary Stents Revenue (USD Billion) and Forecast By Type, 2020-2032
9.2.2. U.S. Coronary Stents Revenue (USD Billion) and Forecast By Biomaterial, 2020-2032
9.2.3. U.S. Coronary Stents Revenue (USD Billion) and Forecast By Mode of Delivery, 2020-2032
9.2.4. U.S. Coronary Stents Revenue (USD Billion) and Forecast By End User, 2020-2032
9.3. Canada
9.3.1. Canada Coronary Stents Revenue (USD Billion) and Forecast By Type, 2020-2032
9.3.2. Canada Coronary Stents Revenue (USD Billion) and Forecast By Biomaterial, 2020-2032
9.3.3. Canada Coronary Stents Revenue (USD Billion) and Forecast By Mode of Delivery, 2020-2032
9.3.4. Canada Coronary Stents Revenue (USD Billion) and Forecast By End User, 2020-2032
9.4. North America PEST Analysis
CHAPTER 10. Europe Coronary Stents Market By Country
10.1. Europe Coronary Stents Market Overview
10.2. U.K.
10.2.1. U.K. Coronary Stents Revenue (USD Billion) and Forecast By Type, 2020-2032
10.2.2. U.K. Coronary Stents Revenue (USD Billion) and Forecast By Biomaterial, 2020-2032
10.2.3. U.K. Coronary Stents Revenue (USD Billion) and Forecast By Mode of Delivery, 2020-2032
10.2.4. U.K. Coronary Stents Revenue (USD Billion) and Forecast By End User, 2020-2032
10.3. Germany
10.3.1. Germany Coronary Stents Revenue (USD Billion) and Forecast By Type, 2020-2032
10.3.2. Germany Coronary Stents Revenue (USD Billion) and Forecast By Biomaterial, 2020-2032
10.3.3. Germany Coronary Stents Revenue (USD Billion) and Forecast By Mode of Delivery, 2020-2032
10.3.4. Germany Coronary Stents Revenue (USD Billion) and Forecast By End User, 2020-2032
10.4. France
10.4.1. France Coronary Stents Revenue (USD Billion) and Forecast By Type, 2020-2032
10.4.2. France Coronary Stents Revenue (USD Billion) and Forecast By Biomaterial, 2020-2032
10.4.3. France Coronary Stents Revenue (USD Billion) and Forecast By Mode of Delivery, 2020-2032
10.4.4. France Coronary Stents Revenue (USD Billion) and Forecast By End User, 2020-2032
10.5. Spain
10.5.1. Spain Coronary Stents Revenue (USD Billion) and Forecast By Type, 2020-2032
10.5.2. Spain Coronary Stents Revenue (USD Billion) and Forecast By Biomaterial, 2020-2032
10.5.3. Spain Coronary Stents Revenue (USD Billion) and Forecast By Mode of Delivery, 2020-2032
10.5.4. Spain Coronary Stents Revenue (USD Billion) and Forecast By End User, 2020-2032
10.6. Rest of Europe
10.6.1. Rest of Europe Coronary Stents Revenue (USD Billion) and Forecast By Type, 2020-2032
10.6.2. Rest of Europe Coronary Stents Revenue (USD Billion) and Forecast By Biomaterial, 2020-2032
10.6.3. Rest of Europe Coronary Stents Revenue (USD Billion) and Forecast By Mode of Delivery, 2020-2032
10.6.4. Rest of Europe Coronary Stents Revenue (USD Billion) and Forecast By End User, 2020-2032
10.7. Europe PEST Analysis
CHAPTER 11. Asia Pacific Coronary Stents Market By Country
11.1. Asia Pacific Coronary Stents Market Overview
11.2. China
11.2.1. China Coronary Stents Revenue (USD Billion) and Forecast By Type, 2020-2032
11.2.2. China Coronary Stents Revenue (USD Billion) and Forecast By Biomaterial, 2020-2032
11.2.3. China Coronary Stents Revenue (USD Billion) and Forecast By Mode of Delivery, 2020-2032
11.2.4. China Coronary Stents Revenue (USD Billion) and Forecast By End User, 2020-2032
11.3. Japan
11.3.1. Japan Coronary Stents Revenue (USD Billion) and Forecast By Type, 2020-2032
11.3.2. Japan Coronary Stents Revenue (USD Billion) and Forecast By Biomaterial, 2020-2032
11.3.3. Japan Coronary Stents Revenue (USD Billion) and Forecast By Mode of Delivery, 2020-2032
11.3.4. Japan Coronary Stents Revenue (USD Billion) and Forecast By End User, 2020-2032
11.4. India
11.4.1. India Coronary Stents Revenue (USD Billion) and Forecast By Type, 2020-2032
11.4.2. India Coronary Stents Revenue (USD Billion) and Forecast By Biomaterial, 2020-2032
11.4.3. India Coronary Stents Revenue (USD Billion) and Forecast By Mode of Delivery, 2020-2032
11.4.4. India Coronary Stents Revenue (USD Billion) and Forecast By End User, 2020-2032
11.5. Australia
11.5.1. Australia Coronary Stents Revenue (USD Billion) and Forecast By Type, 2020-2032
11.5.2. Australia Coronary Stents Revenue (USD Billion) and Forecast By Biomaterial, 2020-2032
11.5.3. Australia Coronary Stents Revenue (USD Billion) and Forecast By Mode of Delivery, 2020-2032
11.5.4. Australia Coronary Stents Revenue (USD Billion) and Forecast By End User, 2020-2032
11.6. South Korea
11.6.1. South Korea Coronary Stents Revenue (USD Billion) and Forecast By Type, 2020-2032
11.6.2. South Korea Coronary Stents Revenue (USD Billion) and Forecast By Biomaterial, 2020-2032
11.6.3. South Korea Coronary Stents Revenue (USD Billion) and Forecast By Mode of Delivery, 2020-2032
11.6.4. South Korea Coronary Stents Revenue (USD Billion) and Forecast By End User, 2020-2032
11.7. Rest of Asia-Pacific
11.7.1. Rest of Asia-Pacific Coronary Stents Revenue (USD Billion) and Forecast By Type, 2020-2032
11.7.2. Rest of Asia-Pacific Coronary Stents Revenue (USD Billion) and Forecast By Biomaterial, 2020-2032
11.7.3. Rest of Asia-Pacific Coronary Stents Revenue (USD Billion) and Forecast By Mode of Delivery, 2020-2032
11.7.4. Rest of Asia-Pacific Coronary Stents Revenue (USD Billion) and Forecast By End User, 2020-2032
11.8. Asia Pacific PEST Analysis
CHAPTER 12. Latin America Coronary Stents Market By Country
12.1. Latin America Coronary Stents Market Overview
12.2. Brazil
12.2.1. Brazil Coronary Stents Revenue (USD Billion) and Forecast By Type, 2020-2032
12.2.2. Brazil Coronary Stents Revenue (USD Billion) and Forecast By Biomaterial, 2020-2032
12.2.3. Brazil Coronary Stents Revenue (USD Billion) and Forecast By Mode of Delivery, 2020-2032
12.2.4. Brazil Coronary Stents Revenue (USD Billion) and Forecast By End User, 2020-2032
12.3. Mexico
12.3.1. Mexico Coronary Stents Revenue (USD Billion) and Forecast By Type, 2020-2032
12.3.2. Mexico Coronary Stents Revenue (USD Billion) and Forecast By Biomaterial, 2020-2032
12.3.3. Mexico Coronary Stents Revenue (USD Billion) and Forecast By Mode of Delivery, 2020-2032
12.3.4. Mexico Coronary Stents Revenue (USD Billion) and Forecast By End User, 2020-2032
12.4. Rest of Latin America
12.4.1. Rest of Latin America Coronary Stents Revenue (USD Billion) and Forecast By Type, 2020-2032
12.4.2. Rest of Latin America Coronary Stents Revenue (USD Billion) and Forecast By Biomaterial, 2020-2032
12.4.3. Rest of Latin America Coronary Stents Revenue (USD Billion) and Forecast By Mode of Delivery, 2020-2032
12.4.4. Rest of Latin America Coronary Stents Revenue (USD Billion) and Forecast By End User, 2020-2032
12.5. Latin America PEST Analysis
CHAPTER 13. Middle East & Africa Coronary Stents Market By Country
13.1. Middle East & Africa Coronary Stents Market Overview
13.2. GCC
13.2.1. GCC Coronary Stents Revenue (USD Billion) and Forecast By Type, 2020-2032
13.2.2. GCC Coronary Stents Revenue (USD Billion) and Forecast By Biomaterial, 2020-2032
13.2.3. GCC Coronary Stents Revenue (USD Billion) and Forecast By Mode of Delivery, 2020-2032
13.2.4. GCC Coronary Stents Revenue (USD Billion) and Forecast By End User, 2020-2032
13.3. South Africa
13.3.1. South Africa Coronary Stents Revenue (USD Billion) and Forecast By Type, 2020-2032
13.3.2. South Africa Coronary Stents Revenue (USD Billion) and Forecast By Biomaterial, 2020-2032
13.3.3. South Africa Coronary Stents Revenue (USD Billion) and Forecast By Mode of Delivery, 2020-2032
13.3.4. South Africa Coronary Stents Revenue (USD Billion) and Forecast By End User, 2020-2032
13.4. Rest of Middle East & Africa
13.4.1. Rest of Middle East & Africa Coronary Stents Revenue (USD Billion) and Forecast By Type, 2020-2032
13.4.2. Rest of Middle East & Africa Coronary Stents Revenue (USD Billion) and Forecast By Biomaterial, 2020-2032
13.4.3. Rest of Middle East & Africa Coronary Stents Revenue (USD Billion) and Forecast By Mode of Delivery, 2020-2032
13.4.4. Rest of Middle East & Africa Coronary Stents Revenue (USD Billion) and Forecast By End User, 2020-2032
13.5. Middle East & Africa PEST Analysis
CHAPTER 14. Player Analysis Of Coronary Stents Market
14.1. Coronary Stents Market Company Share Analysis
14.2. Competition Matrix
14.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
14.2.2. New Product Launches and Product Enhancements
14.2.3. Mergers And Acquisition In Global Coronary Stents Market
14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 15. Company Profile
15.1. Abbott Vascular
15.1.1. Company Snapshot
15.1.2. Business Overview
15.1.3. Financial Overview
15.1.3.1. Revenue (USD Billion), 2022
15.1.3.2. Abbott Vascular 2022 Coronary Stents Business Regional Distribution
15.2. Medtronic
15.3. Boston Scientific
15.4. B. Braun Melsungen AG
15.5. Biotronik SE & Co. KG
15.6. Terumo
15.7. Stentys SA
15.8. Becton Dickinson and Co.
15.9. Cook Group
15.10. SMT
15.11. Micro Port
The coronary stents market size was valued at USD 7.8 billion in 2022.
The CAGR of coronary stents is 8.2% during the analysis period of 2023 to 2032.
The key players operating in the global market are including Abbott Vascular, Medtronic, Boston Scientific, B. Braun Melsungen AG, Biotronik SE & Co. KG, Terumo, Stentys SA, Becton Dickinson and Co., Cook Group, SMT and Micro Port.
North America held the dominating position in coronary stents industry during the analysis period of 2023 to 2032.
Asia-Pacific region exhibited fastest growing CAGR for market of coronary stents during the analysis period of 2023 to 2032.
The current trends and dynamics in the coronary stents industry include increasing prevalence of coronary artery disease, technological advancements in stent design and materials, growing preference for minimally invasive procedures, and rising adoption of percutaneous coronary intervention (PCI) procedures.
The drug eluting stent type held the maximum share of the coronary stents industry.
Customer Satisfaction
Availability - we are always there when you need us
Fortune 50 Companies trust Acumen Research and Consulting
of our reports are exclusive and first in the industry
more data and analysis
reports published till date